Miller W J, Provost P J, McAleer W J, Ittensohn O L, Villarejos V M, Hilleman M R
Proc Soc Exp Biol Med. 1975 May;149(1):254-61. doi: 10.3181/00379727-149-38783.
A specific immune adherence (IA) test for hepatitis A antibody in human serum was described employing liver extract of marmosets infected with CR326 strain human hepatitis A virus. Persons with hepatitis A, but not hepatitis B, developed hepatitis A IA antibody soon after onset of the acute illness and this persisted thereafter. There was very close agreement in the tests for human hepatitis A immune adherence, complement fixing (CF) and neutralizing antibodies. IA antibodies appeared to develop somewhat later than CF or neutralizing antibody. A limited epidemiologic study of a family outbreak of hepatitis A and B in Costa Rica showed simultaneous occurrence of the two diseases and was supportive of the concept that susceptible persons in a country with high hepatitis A prevalence generally acquire their infections at an early age and are immune thereafter. Most persons of high socioeconomic level in an area of low hepatitis A incidence may proceed to adulthood without experience with hepatitis A. Person of low socioeconomic level, however, such as commercial blood bank donors and prisoners, show high incidence of hepatitis A antibody. Hepatitis IA and CF antibodies persisted in human subjects for at least 7 hr after hepatitis A virus infection. Captive chimpanzees and grivet and rhesus monkeys, not given hepatitis A virus, showed evidence of previous experience with human hepatitis A or an antigenically related virus based on tests for hepatitis A antibody. Other subhuman primates, rodents, and swine, not given hepatitis A virus, were without hepatitis A antibody. The IA test provides an excellent tool for diagnostic and epidemiologic investigations of hepatitis A and should be of considerable value to detect hepatitis A virus in attempts to propagate the virus in cell culture. There was considerable difference in hepatitis A IA antibody content of different lots of commercial human immune globulin, though the majority titered 1:4000 or 1:8000.
采用感染CR326株人甲型肝炎病毒的狨猴肝脏提取物,描述了一种检测人血清中甲肝抗体的特异性免疫黏附(IA)试验。甲型肝炎患者而非乙型肝炎患者在急性疾病发作后不久就产生了甲型肝炎IA抗体,并且此后一直存在。人甲型肝炎免疫黏附、补体结合(CF)和中和抗体检测结果非常一致。IA抗体出现的时间似乎比CF或中和抗体稍晚。在哥斯达黎加对一个甲型和乙型肝炎家庭暴发的有限流行病学研究表明,这两种疾病同时发生,支持了这样一种观念,即在甲型肝炎高流行国家,易感人群通常在幼年时感染,此后具有免疫力。在甲型肝炎发病率低的地区,大多数社会经济水平高的人可能成年后都没有感染过甲型肝炎。然而,社会经济水平低的人,如商业血库供血者和囚犯,甲型肝炎抗体发生率很高。甲型肝炎病毒感染后,甲型肝炎IA和CF抗体在人体中至少持续7小时。未感染甲型肝炎病毒的圈养黑猩猩、灰绿猴和恒河猴,根据甲型肝炎抗体检测结果,显示出曾接触过人甲型肝炎或抗原相关病毒的证据。未感染甲型肝炎病毒的其他非人灵长类动物、啮齿动物和猪没有甲型肝炎抗体。IA试验为甲型肝炎的诊断和流行病学调查提供了一个极好的工具,在试图在细胞培养中繁殖该病毒时,对于检测甲型肝炎病毒应该具有相当大的价值。不同批次的商业人免疫球蛋白的甲型肝炎IA抗体含量有很大差异,尽管大多数的效价为1:4000或1:8000。